{"id":22894,"date":"2025-12-08T11:07:30","date_gmt":"2025-12-08T15:07:30","guid":{"rendered":"https:\/\/www.red94.net\/news\/wve-stock-explodes-40-on-obesity-breakthrough-that-doctors-say-changes-everything-about-weight-loss-forever\/"},"modified":"2025-12-08T11:07:39","modified_gmt":"2025-12-08T15:07:39","slug":"81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ","status":"publish","type":"post","link":"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/","title":{"rendered":"WVE stock explodes 40% on obesity breakthrough that doctors say changes everything about weight loss forever"},"content":{"rendered":"<p style='font-size:1.1em;font-weight:500;line-height:1.6;margin-bottom:20px'><b>WVE stock<\/b> soared 40% to 70% on December 8, 2025, after <b>Wave Life Sciences<\/b> announced positive interim Phase 1 data for <b>WVE-007<\/b>, its experimental obesity treatment. The <b>INLIGHT trial<\/b> results showed the single-dose RNA therapy achieved fat loss comparable to semaglutide while preserving muscle mass\u2014a major breakthrough in obesity treatment.<\/p>\n<div style='background:#f9f9f9;padding:20px;border-left:4px solid #e74c3c;margin:25px 0'>\n<h3 style='margin-top:0'>\ud83d\udd25 Quick Facts<\/h3>\n<ul style='margin:10px 0;padding-left:20px'>\n<li><b>Stock surge:<\/b> WVE stock climbed 40-70% on December 8, 2025, following data announcement<\/li>\n<li><b>Trial results:<\/b> Single 240 mg dose of WVE-007 reduced visceral fat by 9.4% and total body fat by 4.5% at three months<\/li>\n<li><b>Key advantage:<\/b> <b>Weight loss driven purely by fat reduction<\/b> while preserving lean muscle mass unlike some competitors<\/li>\n<li><b>Next steps:<\/b> Wave plans <b>Phase 2 trials<\/b> in early 2026 with potential for once or twice-yearly dosing<\/li>\n<\/ul>\n<\/div>\n<h2>Obesity Treatment Reaches New Milestone with WVE-007 Data<\/h2>\n<p><b>Wave Life Sciences<\/b> revealed interim results from the <b>INLIGHT Phase 1 trial<\/b> on December 8, 2025, demonstrating that <b>WVE-007<\/b> produces meaningful fat loss in overweight and obese patients. The first-in-human study evaluated participants with <b>3:1 active to placebo ratio<\/b>, making the results statistically reliable for early-stage research.<\/p>\n<p>Following a single <b>subcutaneous 240 mg dose<\/b>, patients showed improvements in body composition after just three months. The drug works by silencing the <b>INHBE gene<\/b> using GalNAc-siRNA technology, forcing the body to burn stored fat while maintaining muscle tissue\u2014a critical distinction from weight loss medications that can cause muscle loss alongside fat reduction.<\/p>\n<h2>Comparing WVE-007 to Semaglutide and Other Obesity Drugs<\/h2>\n<p>The clinical data positions <b>WVE-007<\/b> as potentially competitive with GLP-1 receptor agonists like semaglutide and tirzepatide. The trial achieved <b>fat reduction on par with semaglutide results<\/b> by the six-month postdose timeframe, according to Wave&#8217;s statements. Unlike injectable GLP-1 drugs requiring weekly or biweekly injections, the INHBE inhibitor approach offers potential for <b>once or twice-yearly dosing<\/b> based on preliminary biomarker analysis.<\/p>\n<p>The approach represents a fundamentally different mechanism\u2014targeting the genetic driver of weight gain rather than appetite suppression. Safety data reported as &#8220;clean,&#8221; with no serious adverse events mentioned in interim readouts, though longer-term safety observation continues in ongoing phases.<\/p>\n<table style='width:100%;border-collapse:collapse;margin:20px 0'>\n<tr style='background:#f4f4f4'>\n<td style='padding:12px;border:1px solid #ddd;font-weight:bold'>Clinical Metric<\/td>\n<td style='padding:12px;border:1px solid #ddd;font-weight:bold'>WVE-007 Results<\/td>\n<\/tr>\n<tr>\n<td style='padding:12px;border:1px solid #ddd'>Visceral Fat Reduction<\/td>\n<td style='padding:12px;border:1px solid #ddd'>9.4% at 3 months<\/td>\n<\/tr>\n<tr style='background:#f9f9f9'>\n<td style='padding:12px;border:1px solid #ddd'>Total Body Fat Reduction<\/td>\n<td style='padding:12px;border:1px solid #ddd'>4.5% at 3 months<\/td>\n<\/tr>\n<tr>\n<td style='padding:12px;border:1px solid #ddd'>Dose Required<\/td>\n<td style='padding:12px;border:1px solid #ddd'>Single 240 mg subcutaneous injection<\/td>\n<\/tr>\n<tr style='background:#f9f9f9'>\n<td style='padding:12px;border:1px solid #ddd'>Potential Dosing Frequency<\/td>\n<td style='padding:12px;border:1px solid #ddd'>Once or twice yearly (projected)<\/td>\n<\/tr>\n<tr>\n<td style='padding:12px;border:1px solid #ddd'>Mechanism<\/td>\n<td style='padding:12px;border:1px solid #ddd'>GalNAc-siRNA silencing INHBE gene<\/td>\n<\/tr>\n<\/table>\n<h2>Investor Reaction and Market Implications<\/h2>\n<p>Markets responded enthusiastically to the <b>INLIGHT data release<\/b>, with WVE stock gaining 40% by the time markets closed on December 8, and trading volatility pushing peak gains to 70% intraday. The surge reflects investor confidence that <b>RNA medicine<\/b> can deliver real-world obesity treatment benefits. <b>Wave Life Sciences<\/b> is now positioned among the few companies with clinical data supporting next-generation obesity therapeutics beyond traditional inject-and-wait GLP-1 approaches.<\/p>\n<p>Financial analysts note the stock movement suggests market participants believe WVE-007 could capture meaningful market share in the multibillion-dollar obesity treatment sector. The company&#8217;s valuation jumped significantly as a result of demonstrating clinical efficacy, potentially opening doors for partnerships or accelerated development timelines. Biotech investors are particularly watching obesity programs given the market opportunity size and patient demand.<\/p>\n<blockquote style='border-left:4px solid #3498db;padding-left:20px;margin:25px 0;font-style:italic;color:#555'><p>\n&#8220;With a strong foundation in human genetics, WVE-007 is focused on healthy weight loss driven by fat loss, particularly visceral fat loss, which relates to metabolic disease.&#8221;\n<\/p><\/blockquote>\n<p style='font-size:0.9em;color:#666;margin-top:-15px'>\u2014 <b>Wave Life Sciences<\/b>, Company Statement<\/p>\n<h2>What Does the Phase 2 Strategy Reveal About WVE-007&#8217;s Future?<\/h2>\n<p><b>Wave Life Sciences<\/b> announced plans to launch <b>Phase 2 trials<\/b> starting in early 2026, testing both monotherapy and combination approaches. The company plans to evaluate WVE-007 alongside <b>incretin-based therapies<\/b> in patients with higher BMI and metabolic conditions, suggesting confidence in combining RNA-based fat loss drivers with established diabetes medications.<\/p>\n<p>This strategy indicates researchers believe RNA therapies and traditional medications could work synergistically. The Phase 2 strategy also addresses practical concerns about patient populations\u2014moving beyond lean healthy volunteers in Phase 1 to real-world obese populations with comorbidities. Timeline projections suggest potential Phase 2 readouts could emerge in late 2026 or 2027, meaning investors face a multiyear holding period before pivotal Phase 3 could commence.<\/p>\n<p>The obesity drug market continues expanding rapidly as medical understanding evolves around weight&#8217;s connection to chronic disease. <b>WVE-007&#8217;s mechanism<\/b>\u2014targeting genetic drivers rather than symptoms\u2014represents genuine innovation. Market participants now watch whether Wave&#8217;s Phase 2 data sustains the optimism generated by these Phase 1 results.<\/p>\n<h3>Sources<\/h3>\n<ul>\n<li><b>Wave Life Sciences Official Release<\/b> \u2014 Positive interim INLIGHT Phase 1 trial data announcement<\/li>\n<li><b>RTTNews<\/b> \u2014 WVE-007 clinical trial results and stock surge coverage<\/li>\n<li><b>Investing.com<\/b> \u2014 Market response and stock price analysis<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":23,"featured_media":22893,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"schema_org_data":"{\"@context\":\"https:\/\/schema.org\",\"@graph\":[]}","_extracted_celebrities":"","_extracted_movies":"","_extracted_places":"","_extracted_videos":"","_last_enrichment_date":"2025-12-08 11:07:45","footnotes":""},"categories":[391],"tags":[],"class_list":["post-22894","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-finance","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-33"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>WVE stock explodes 40% on obesity breakthrough that doctors say changes everything about weight loss forever<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"WVE stock explodes 40% on obesity breakthrough that doctors say changes everything about weight loss forever\" \/>\n<meta property=\"og:description\" content=\"&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/\" \/>\n<meta property=\"og:site_name\" content=\"Red94\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-08T15:07:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-08T15:07:39+00:00\" \/>\n<meta name=\"author\" content=\"Patrick Graham\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Patrick Graham\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/\"},\"author\":{\"name\":\"Patrick Graham\",\"@id\":\"https:\/\/www.red94.net\/news\/#\/schema\/person\/a87cd0001445db88250833ec7b7ce9a9\"},\"headline\":\"WVE stock explodes 40% on obesity breakthrough that doctors say changes everything about weight loss forever\",\"datePublished\":\"2025-12-08T15:07:30+00:00\",\"dateModified\":\"2025-12-08T15:07:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/\"},\"wordCount\":724,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.red94.net\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/69939-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ.jpg.png\",\"articleSection\":[\"Business &amp; Finance\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/\",\"url\":\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/\",\"name\":\"WVE stock explodes 40% on obesity breakthrough that doctors say changes everything about weight loss forever\",\"isPartOf\":{\"@id\":\"https:\/\/www.red94.net\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/69939-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ.jpg.png\",\"datePublished\":\"2025-12-08T15:07:30+00:00\",\"dateModified\":\"2025-12-08T15:07:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#primaryimage\",\"url\":\"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/69939-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ.jpg.png\",\"contentUrl\":\"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/69939-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ.jpg.png\",\"width\":1360,\"height\":768,\"caption\":\"WVE stock soars 40% as Wave Life Sciences reveals positive obesity drug data, targets fat loss breakthrough\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.red94.net\/news\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Entertainment\",\"item\":\"https:\/\/www.red94.net\/news\/entertainment\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"WVE stock explodes 40% on obesity breakthrough that doctors say changes everything about weight loss forever\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.red94.net\/news\/#website\",\"url\":\"https:\/\/www.red94.net\/news\/\",\"name\":\"Red94\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.red94.net\/news\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.red94.net\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.red94.net\/news\/#organization\",\"name\":\"Red94\",\"url\":\"https:\/\/www.red94.net\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.red94.net\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/07\/Logo-Red94.png\",\"contentUrl\":\"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/07\/Logo-Red94.png\",\"width\":289,\"height\":90,\"caption\":\"Red94\"},\"image\":{\"@id\":\"https:\/\/www.red94.net\/news\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.red94.net\/news\/#\/schema\/person\/a87cd0001445db88250833ec7b7ce9a9\",\"name\":\"Patrick Graham\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.red94.net\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/www.red94.net\/news\/wp-content\/plugins\/generateperf\/images\/icons\/avatar.svg\",\"contentUrl\":\"https:\/\/www.red94.net\/news\/wp-content\/plugins\/generateperf\/images\/icons\/avatar.svg\",\"caption\":\"Patrick Graham\"},\"description\":\"Patrick Graham is a business and finance journalist translating Wall Street's complexities into stories that matter to everyday readers. With extensive experience in financial journalism and economic analysis, this expert journalist provides sharp insights on market trends, corporate developments, and the economic forces affecting daily life. His reporting helps readers make sense of the business world's biggest moves.\",\"url\":\"https:\/\/www.red94.net\/news\/author\/patrick-graham\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"WVE stock explodes 40% on obesity breakthrough that doctors say changes everything about weight loss forever","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/","og_locale":"en_US","og_type":"article","og_title":"WVE stock explodes 40% on obesity breakthrough that doctors say changes everything about weight loss forever","og_description":"&hellip;","og_url":"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/","og_site_name":"Red94","article_published_time":"2025-12-08T15:07:30+00:00","article_modified_time":"2025-12-08T15:07:39+00:00","author":"Patrick Graham","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Patrick Graham","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#article","isPartOf":{"@id":"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/"},"author":{"name":"Patrick Graham","@id":"https:\/\/www.red94.net\/news\/#\/schema\/person\/a87cd0001445db88250833ec7b7ce9a9"},"headline":"WVE stock explodes 40% on obesity breakthrough that doctors say changes everything about weight loss forever","datePublished":"2025-12-08T15:07:30+00:00","dateModified":"2025-12-08T15:07:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/"},"wordCount":724,"commentCount":0,"publisher":{"@id":"https:\/\/www.red94.net\/news\/#organization"},"image":{"@id":"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#primaryimage"},"thumbnailUrl":"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/69939-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ.jpg.png","articleSection":["Business &amp; Finance"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/","url":"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/","name":"WVE stock explodes 40% on obesity breakthrough that doctors say changes everything about weight loss forever","isPartOf":{"@id":"https:\/\/www.red94.net\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#primaryimage"},"image":{"@id":"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#primaryimage"},"thumbnailUrl":"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/69939-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ.jpg.png","datePublished":"2025-12-08T15:07:30+00:00","dateModified":"2025-12-08T15:07:39+00:00","breadcrumb":{"@id":"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#primaryimage","url":"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/69939-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ.jpg.png","contentUrl":"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/12\/69939-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ.jpg.png","width":1360,"height":768,"caption":"WVE stock soars 40% as Wave Life Sciences reveals positive obesity drug data, targets fat loss breakthrough"},{"@type":"BreadcrumbList","@id":"https:\/\/www.red94.net\/news\/81680-wve-stock-soars-40-as-wave-life-sciences-reveals-positive-obesity-drug-data-targ\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.red94.net\/news\/"},{"@type":"ListItem","position":2,"name":"Entertainment","item":"https:\/\/www.red94.net\/news\/entertainment\/"},{"@type":"ListItem","position":3,"name":"WVE stock explodes 40% on obesity breakthrough that doctors say changes everything about weight loss forever"}]},{"@type":"WebSite","@id":"https:\/\/www.red94.net\/news\/#website","url":"https:\/\/www.red94.net\/news\/","name":"Red94","description":"","publisher":{"@id":"https:\/\/www.red94.net\/news\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.red94.net\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.red94.net\/news\/#organization","name":"Red94","url":"https:\/\/www.red94.net\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.red94.net\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/07\/Logo-Red94.png","contentUrl":"https:\/\/www.red94.net\/news\/wp-content\/uploads\/2025\/07\/Logo-Red94.png","width":289,"height":90,"caption":"Red94"},"image":{"@id":"https:\/\/www.red94.net\/news\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.red94.net\/news\/#\/schema\/person\/a87cd0001445db88250833ec7b7ce9a9","name":"Patrick Graham","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.red94.net\/news\/#\/schema\/person\/image\/","url":"https:\/\/www.red94.net\/news\/wp-content\/plugins\/generateperf\/images\/icons\/avatar.svg","contentUrl":"https:\/\/www.red94.net\/news\/wp-content\/plugins\/generateperf\/images\/icons\/avatar.svg","caption":"Patrick Graham"},"description":"Patrick Graham is a business and finance journalist translating Wall Street's complexities into stories that matter to everyday readers. With extensive experience in financial journalism and economic analysis, this expert journalist provides sharp insights on market trends, corporate developments, and the economic forces affecting daily life. His reporting helps readers make sense of the business world's biggest moves.","url":"https:\/\/www.red94.net\/news\/author\/patrick-graham\/"}]}},"views":456,"_links":{"self":[{"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/posts\/22894","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/comments?post=22894"}],"version-history":[{"count":0,"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/posts\/22894\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/media\/22893"}],"wp:attachment":[{"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/media?parent=22894"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/categories?post=22894"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.red94.net\/news\/wp-json\/wp\/v2\/tags?post=22894"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}